TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/3/25 17:16 | 8/29/25 | SION | Sionna Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ridloff Elena | MA | O | CFO,Head | S.m | -240 | 25.09 | 0 | -10 | -20 | 39 | D | ||||||||||||||
8/28/25 17:40 | 8/26/25 | SION | Sionna Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ridloff Elena | MA | O | CFO,Head | S.m | -602 | 25.70 | 0 | -23 | -33 | 48 | D | ||||||||||||||
8/21/25 16:04 | 8/19/25 | SION | Sionna Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ridloff Elena | MA | O | CFO,Head | S.m | -1,124 | 21.62 | 0 | -52 | -42 | 72 | D | ||||||||||||||
6/11/25 16:47 | 6/11/25 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ridloff Elena | MA | D | S.d | -225 | 50.00 | 0 | -5 | -100 | 0 | D | |||||||||||||||
6/3/25 18:30 | 6/3/25 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ridloff Elena | MA | D | S.d | -553 | 46.10 | 0 | -12 | -100 | 0 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |